These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 35008604)

  • 1. Pathophysiology of the Different Clinical Phenotypes of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP).
    Dziadkowiak E; Waliszewska-Prosół M; Nowakowska-Kotas M; Budrewicz S; Koszewicz Z; Koszewicz M
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
    Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
    J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Clinical Features, Diagnosis, and Current Treatment Strategies.
    Reynolds J; Sachs G; Stavros K
    R I Med J (2013); 2016 Dec; 99(12):32-35. PubMed ID: 27902997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy.
    Mathis S; Vallat JM; Magy L
    Immunotherapy; 2016 Feb; 8(2):165-78. PubMed ID: 26809024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy].
    Kanbayashi T; Sonoo M
    Brain Nerve; 2015 Nov; 67(11):1388-96. PubMed ID: 26560954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Inflammatory Demyelinating Polyneuropathy.
    Kuwabara S; Misawa S
    Adv Exp Med Biol; 2019; 1190():333-343. PubMed ID: 31760654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go.
    Nobile-Orazio E
    J Peripher Nerv Syst; 2014 Mar; 19(1):2-13. PubMed ID: 24612201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term and long-term effects of immunoadsorption in refractory chronic inflammatory demyelinating polyneuropathy: a prospective study in 17 patients.
    Dorst J; Ludolph AC; Senel M; Tumani H
    J Neurol; 2018 Dec; 265(12):2906-2915. PubMed ID: 30293110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics and Treatment Response of Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    Suanprasert N; Hanchaiphiboolkul S
    J Med Assoc Thai; 2017 Mar; 100(3):262-9. PubMed ID: 29911781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refractory Chronic Immune-mediated Demyelinating Polyneuropathy.
    Shaibani A; Al Sultani H
    Neurol Clin; 2020 Aug; 38(3):591-605. PubMed ID: 32703471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic inflammatory demyelinating polyneuropathy and other immune-mediated demyelinating neuropathies.
    Lewis RA
    Semin Neurol; 2005 Jun; 25(2):217-28. PubMed ID: 15937737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences between acute-onset chronic inflammatory demyelinating polyneuropathy and acute inflammatory demyelinating polyneuropathy in adult patients.
    Alessandro L; Pastor Rueda JM; Wilken M; Querol L; Marrodán M; Acosta JN; Rivero A; Barroso F; Farez MF
    J Peripher Nerv Syst; 2018 Sep; 23(3):154-158. PubMed ID: 29603827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute-onset chronic inflammatory demyelinating polyneuropathy: An electrodiagnostic study.
    Anadani M; Katirji B
    Muscle Nerve; 2015 Nov; 52(5):900-5. PubMed ID: 25809534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in Hematopoietic Stem Cell Transplantation for CIDP.
    Qin Z; Huang Q; Zou J; Tang L; Hu Z; Tang X
    Int J Med Sci; 2020; 17(2):234-241. PubMed ID: 32038107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyneuropathies and chronic inflammatory demyelinating polyradiculoneuropathy in multiple sclerosis.
    Suanprasert N; Taylor BV; Klein CJ; Roforth MM; Karam C; Keegan BM; Dyck PJB
    Mult Scler Relat Disord; 2019 May; 30():284-290. PubMed ID: 30870805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Lewis-Sumner syndrome with chronic inflammatory demyelinating polyradiculoneuropathy patients in a tertiary care centre.
    Fargeot G; Maisonobe T; Psimaras D; Debs R; Lenglet T; Adams D; Vandendries C; Labeyrie C; Viala K
    Eur J Neurol; 2020 Mar; 27(3):522-528. PubMed ID: 31574194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment options.
    Eftimov F; van Schaik I
    Curr Opin Neurol; 2013 Oct; 26(5):496-502. PubMed ID: 23852276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatigue in chronic inflammatory demyelinating polyneuropathy.
    Gable KL; Attarian H; Allen JA
    Muscle Nerve; 2020 Dec; 62(6):673-680. PubMed ID: 32710648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management strategies in chronic inflammatory demyelinating polyradiculoneuropathy.
    Patel K; Bhanushali M; Muley SA
    Neurol India; 2010; 58(3):351-60. PubMed ID: 20644261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current concepts and controversy in chronic inflammatory demyelinating polyneuropathy.
    Saperstein DS; Barohn RJ
    Curr Neurol Neurosci Rep; 2003 Jan; 3(1):57-63. PubMed ID: 12507413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.